Recruiting NA INTERVENTIONAL 1-arm NCT05696522

Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia (SABRE-VT)

Sponsor: Barts & The London NHS Trust

Conditions Heart Failure Radiotherapy; Complications Structural Heart Abnormality Ventricular Tachycardia

Interventions Stereotactic ablative radiotherapy

Updated 5 times since 2023 Last updated: Jun 18, 2025 Started: Jan 12, 2023 Primary completion: May 2, 2026 Completion: May 2, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05696522, this NA trial focuses on Heart Failure and Radiotherapy; Complications and remains actively recruiting participants. Sponsored by Barts & The London NHS Trust, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Jul 2025 — Present [monthly]

Recruiting NA
Dec 2024 — Jul 2025 [monthly]

Recruiting NA
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Barts & The London NHS Trust

Data source: Barts & The London NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom